Lonza News 9 avr. 2026 Lonza Redefines Bioprocess Efficiency In APAC With Advanced Media Development Lab - BioSpectrum Asia
Lonza News 8 avr. 2026 Lonza Group AG stock: What investors need to know for long-term growth - AD HOC NEWS
Lonza News 8 avr. 2026 ImmuneOncia signs manufacturing agreement with Lonza for Danburstotug - Drug Discovery News
Lonza News 7 avr. 2026 Lonza Nominates Stephen Fry as Independent Board Member - Manufacturing Chemist
Lonza News 7 avr. 2026 Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development - Manufacturing Chemist
Lonza News 6 avr. 2026 Lonza Group AG stock: What investors should know about its biotech edge now - AD HOC NEWS
Lonza News 2 avr. 2026 Formulating Plant-Based and Organic Supplements: A Conversation with Lonza CHI - Nutritional Outlook
Lonza News 2 avr. 2026 Swiss Rockets Collaborates with Lonza to Advance Torqur’s Oncology Drug Candidate Bimiralisib into Late-Stage Clinical Development - the-scientist.com
Lonza News 2 avr. 2026 Lonza to manufacture ImmuneOncia’s antibody for rare type of lymphoma - BioProcess International
Lonza News 2 avr. 2026 ImmuneOncia Therapeutics and Lonza collaborate to manufacture Danburstotug - Manufacturing Chemist
Lonza News 1 avr. 2026 Lonza Group (SWX:LONN) Is Up 5.8% After 25% Dividend Hike And Board Refresh - Has The Bull Case Changed? - simplywall.st
Lonza News 1 avr. 2026 Lonza: Growth Intact, CHI Exit Strengthens Focus, Recent Dip Opens Opportunity (LZAGY) - Seeking Alpha